Saturday, February 9, 2013

• 2 Rising Healthcare Stocks to Watch Nowat Wall St. Cheat Sheet (Sat, Feb 9)
• 3 Humongous Health-Care Stocks This Weekat Motley Fool (Sat, Feb 9)

Friday, February 8, 2013

• LinkedIn, AOL, Coinstar are market moversAP (Fri, Feb 8)
• Neurocrine Biosciences' CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Fri, Feb 8)
• Neurocrine 4Q profit jumps due to collaborationAP (Fri, Feb 8)
• Neurocrine Biosciences Earnings: Here’s Why Shares are Popping Higher Nowat Wall St. Cheat Sheet (Fri, Feb 8)
• NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online (Fri, Feb 8)
• Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 ResultsPR Newswire (Fri, Feb 8)

Wednesday, February 6, 2013

• Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013PR Newswire (Wed, Feb 6)
• Biotech Companies Attractive Targets for Pharmaceutical Companies Looking to Replace Lost RevenuesMarketwired (Wed, Feb 6)

Friday, February 1, 2013

• Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial ResultsPR Newswire (Fri, Feb 1)

Thursday, January 24, 2013

• 4 Healthcare Stock Stories Prescribed for Investorsat Wall St. Cheat Sheet (Thu, Jan 24)

Monday, January 14, 2013

• NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Mon, Jan 14)

Monday, January 7, 2013

• Neurocrine Biosciences: Elagolix-Channel Checks And Expert Opinion Reveal Small Market Size, Unfavorable Incentivesat Seeking Alpha (Mon, Jan 7)

Tuesday, December 4, 2012

• Neurocrine Biosciences Presents at Deutsche Bank's 2012 dbAccess BioFEST (Transcript)at Seeking Alpha (Tue, Dec 4)

Tuesday, November 13, 2012

• Neurocrine Biosciences' CEO Presents at Lazard Capital Market's 9th Annual Healthcare Conference (Transcript)at Seeking Alpha (Tue, Nov 13)

Wednesday, November 7, 2012

• The Most Promising Dividends in Pharmaceutical Companiesat Motley Fool (Wed, Nov 7)
• Neurocrine Biosciences Inc. Stock Downgraded (NBIX)at TheStreet (Wed, Nov 7)

Wednesday, October 31, 2012

• Neurocrine Biosciences' CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Oct 31)
• Neurocrine posts 3Q loss from profit a year agoAP (Wed, Oct 31)
• Neurocrine Biosciences Earnings: Swings to a Loss, Falling Short of Estimatesat Wall St. Cheat Sheet (Wed, Oct 31)
• NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online (Wed, Oct 31)

Monday, October 8, 2012

• Need An Alternative To Stocks Like Merck And Abbott Labs? Try Neurocrine Biosciencesat Seeking Alpha (Mon, Oct 8)

Thursday, October 4, 2012

• New Stock Coverage: TripAdvisor Going Placesat Minyanville (Thu, Oct 4)

Tuesday, October 2, 2012

• Merck Finds Gardisil To Be Safe In The Short Term and 2 Other Companies Continue Drug Trialsat Wall St. Cheat Sheet (Tue, Oct 2)

Add NBIX News to My Yahoo!